Cocrystal Pharma, Inc. (COCP)
1.21
+0.07
(+6.14%)
USD |
NASDAQ |
Sep 18, 16:00
1.23
+0.02
(+1.65%)
After-Hours: 20:00
Cocrystal Pharma Free Cash Flow : -8.276M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.276M |
| March 31, 2026 | -8.007M |
| December 31, 2025 | -8.606M |
| September 30, 2025 | -9.320M |
| June 30, 2025 | -12.07M |
| March 31, 2025 | -13.44M |
| December 31, 2024 | -15.01M |
| September 30, 2024 | -15.38M |
| June 30, 2024 | -14.12M |
| March 31, 2024 | -16.29M |
| December 31, 2023 | -14.93M |
| September 30, 2023 | -17.32M |
| June 30, 2023 | -23.23M |
| March 31, 2023 | -21.24M |
| December 31, 2022 | -21.99M |
| September 30, 2022 | -19.28M |
| June 30, 2022 | -15.73M |
| March 31, 2022 | -14.60M |
| December 31, 2021 | -12.48M |
| September 30, 2021 | -12.91M |
| June 30, 2021 | -10.72M |
| March 31, 2021 | -10.05M |
| December 31, 2020 | -10.53M |
| September 30, 2020 | -8.735M |
| June 30, 2020 | -6.956M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.982M |
| December 31, 2019 | -1.708M |
| September 30, 2019 | -2.181M |
| June 30, 2019 | -3.006M |
| March 31, 2019 | -3.996M |
| December 31, 2018 | -8.072M |
| September 30, 2018 | -7.556M |
| June 30, 2018 | -7.695M |
| March 31, 2018 | -6.918M |
| December 31, 2017 | -6.920M |
| September 30, 2017 | -7.557M |
| June 30, 2017 | -7.948M |
| March 31, 2017 | -11.87M |
| December 31, 2016 | -13.85M |
| September 30, 2016 | -15.06M |
| June 30, 2016 | -15.27M |
| March 31, 2016 | -12.60M |
| December 31, 2015 | -10.10M |
| September 30, 2015 | -8.570M |
| June 30, 2015 | -6.679M |
| March 31, 2015 | -5.552M |
| December 31, 2014 | -5.768M |
| September 30, 2014 | -7.807M |
| June 30, 2014 | -7.031M |
| March 31, 2014 | -6.347M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -208.80M |
| Fulcrum Therapeutics, Inc. | -66.14M |
| Definium Therapeutics, Inc. | -166.74M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.536M |
| Free Cash Flow Per Share (Quarterly) | -0.1839 |
| Free Cash Flow to Equity (Quarterly) | -2.453M |
| Free Cash Flow to Firm (Quarterly) | -2.536M |
| Free Cash Flow Yield | -52.26% |